• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata.

作者信息

Bayart Cheryl B, DeNiro Katherine L, Brichta Lars, Craiglow Brittany G, Sidbury Robert

机构信息

Department of Pediatrics, Division of Dermatology, Seattle Children's Hospital, Seattle, Washington.

Department of Pediatrics, Division of Dermatology, Seattle Children's Hospital, Seattle, Washington.

出版信息

J Am Acad Dermatol. 2017 Jul;77(1):167-170. doi: 10.1016/j.jaad.2017.03.024.

DOI:10.1016/j.jaad.2017.03.024
PMID:28619556
Abstract
摘要

相似文献

1
Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata.用于治疗儿童斑秃的局部Janus激酶抑制剂。
J Am Acad Dermatol. 2017 Jul;77(1):167-170. doi: 10.1016/j.jaad.2017.03.024.
2
Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata.与使用JAK抑制剂治疗斑秃相关的反跳效应。
J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e156-e157. doi: 10.1111/jdv.15383. Epub 2019 Jan 1.
3
Tofacitinib therapy for children with severe alopecia areata.托法替布治疗儿童重度斑秃
J Am Acad Dermatol. 2019 Apr;80(4):1164-1166. doi: 10.1016/j.jaad.2018.12.041. Epub 2019 Jan 8.
4
Response of alopecia areata of the beard to oral tofacitinib.胡须斑秃对口服托法替布的反应
J Am Acad Dermatol. 2020 May;82(5):1228-1230. doi: 10.1016/j.jaad.2019.10.058. Epub 2019 Oct 31.
5
JAK Inhibitors for the Treatment of Pediatric Alopecia Areata.用于治疗儿童斑秃的JAK抑制剂
J Investig Dermatol Symp Proc. 2020 Nov;20(1):S31-S36. doi: 10.1016/j.jisp.2020.04.005.
6
Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.口服或外用托法替布成功治疗重度斑秃
J Drugs Dermatol. 2018 Jul 1;17(7):800-803.
7
Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents.托法替布用于治疗成人和青少年重度斑秃
J Investig Dermatol Symp Proc. 2018 Jan;19(1):S18-S20. doi: 10.1016/j.jisp.2017.10.003.
8
Topical tofacitinib in treatment of alopecia areata.局部应用托法替布治疗斑秃。
Einstein (Sao Paulo). 2020;18:eAI5452. doi: 10.31744/einstein_journal/2020ai5452. Epub 2020 Aug 10.
9
A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.一项关于2%托法替布乳膏联合窄谱中波紫外线治疗面部白癜风的初步研究。
J Am Acad Dermatol. 2019 Aug;81(2):646-648. doi: 10.1016/j.jaad.2019.04.032. Epub 2019 Apr 19.
10
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients.2%托法替布软膏，一种局部应用的Janus激酶抑制剂，用于斑秃治疗：一项针对10例患者的初步研究。
J Am Acad Dermatol. 2018 Feb;78(2):403-404.e1. doi: 10.1016/j.jaad.2017.10.043. Epub 2017 Nov 3.

引用本文的文献

1
Off-Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives.外用芦可替尼在皮肤科的超说明书用药：系统文献综述与当前观点
Exp Dermatol. 2025 Apr;34(4):e70095. doi: 10.1111/exd.70095.
2
Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series.天然JAK抑制剂Brevilin-A治疗儿童斑秃的疗效与耐受性：病例系列
Clin Cosmet Investig Dermatol. 2024 Oct 5;17:2225-2230. doi: 10.2147/CCID.S461557. eCollection 2024.
3
Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy.
用于脱发治疗的 siRNA 治疗药物的递药策略。
Int J Mol Sci. 2024 Jul 11;25(14):7612. doi: 10.3390/ijms25147612.
4
Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis.JAK抑制剂治疗中度至重度斑秃的疗效和安全性比较：一项系统评价和网状Meta分析
Front Pharmacol. 2024 Apr 10;15:1372810. doi: 10.3389/fphar.2024.1372810. eCollection 2024.
5
Treatment Options for Alopecia Areata in Children and Adolescents.儿童和青少年斑秃的治疗选择。
Paediatr Drugs. 2024 May;26(3):245-257. doi: 10.1007/s40272-024-00620-2. Epub 2024 Mar 11.
6
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story.JAKinib 的选择性、疗效和安全性：一个仍在不断发展的故事的新证据。
Ann Rheum Dis. 2024 Jan 11;83(2):139-160. doi: 10.1136/ard-2023-223850.
7
Alopecia Areata: Current Treatments and New Directions.斑秃：现有治疗方法和新方向。
Am J Clin Dermatol. 2023 Nov;24(6):895-912. doi: 10.1007/s40257-023-00808-1. Epub 2023 Aug 22.
8
Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review.Janus 激酶抑制剂在斑秃患者中的安全性：系统评价。
Clin Drug Investig. 2023 May;43(5):325-334. doi: 10.1007/s40261-023-01260-z. Epub 2023 May 3.
9
Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata.一名青少年泛发性斑秃患者使用乌帕替尼成功治疗——病例报告及关于JAK抑制剂在儿童斑秃中应用的文献综述
Dermatol Ther (Heidelb). 2023 Mar;13(3):843-856. doi: 10.1007/s13555-023-00889-0. Epub 2023 Jan 13.
10
IADVL SIG Pediatric Dermatology (Academy) Recommendations on Childhood Alopecia Areata.国际皮肤性病学会儿童皮肤病学（学会）关于儿童斑秃的建议。
Indian Dermatol Online J. 2022 Oct 31;13(6):710-720. doi: 10.4103/idoj.idoj_54_22. eCollection 2022 Nov-Dec.